Ernexa Therapeutics Inc. Amortization of Intangible Assets
Ernexa Therapeutics Inc. (ERNA) reported Amortization of Intangible Assets of $29.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2019-03-22
- Ernexa Therapeutics Inc. amortization of intangible assets for the quarter ending 2014-12-31 was $25.00K, a 74.75% decline year-over-year.
- Ernexa Therapeutics Inc. amortization of intangible assets for the quarter ending 2014-09-30 was $44.00K, a 57.69% decline year-over-year.
- Ernexa Therapeutics Inc. amortization of intangible assets for the quarter ending 2014-06-30 was $46.00K, a 56.19% decline year-over-year.
- Ernexa Therapeutics Inc. amortization of intangible assets for the quarter ending 2014-03-31 was $66.00K, a 40.00% decline year-over-year.
- Ernexa Therapeutics Inc. amortization of intangible assets for fiscal 2018 was $29.00K, a 0.00% change from fiscal 2017.
- Ernexa Therapeutics Inc. amortization of intangible assets for fiscal 2017 was $29.00K, a 42.00% decline from fiscal 2016.
- Ernexa Therapeutics Inc. amortization of intangible assets for fiscal 2016 was $50.00K, a 0.00% change from fiscal 2015.
- Ernexa Therapeutics Inc. amortization of intangible assets for fiscal 2015 was $50.00K, a 72.38% decline from fiscal 2014.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2018-12-31 | $29.00K 10-K · filed 2019-03-22 | |||
| 2017-12-31 | $29.00K 10-K · filed 2018-03-09 | |||
| 2016-12-31 | $50.00K 10-K · filed 2018-03-09 | |||
| 2015-12-31 | $50.00K 10-K · filed 2017-03-09 | |||
| 2014-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $69.00K derived: sum of 2 quarters · filed 2016-03-15 | $115.00K derived: sum of 3 quarters · filed 2016-03-15 | $181.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $44.00K 10-Q · filed 2014-11-07 | $90.00K derived: sum of 2 quarters · filed 2014-11-07 | $156.00K 10-Q · filed 2014-11-07 | $255.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-06-30 | $46.00K 10-Q · filed 2014-08-14 | $112.00K 10-Q · filed 2014-08-14 | $211.00K derived: sum of 3 quarters · filed 2015-03-27 | $315.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-03-31 | $66.00K 10-Q · filed 2014-05-15 | $165.00K derived: sum of 2 quarters · filed 2015-03-27 | $269.00K derived: sum of 3 quarters · filed 2015-03-27 | $374.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $203.00K derived: sum of 2 quarters · filed 2015-03-27 | $308.00K derived: sum of 3 quarters · filed 2015-03-27 | $418.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $104.00K 10-Q · filed 2014-11-07 | $209.00K derived: sum of 2 quarters · filed 2014-11-07 | $319.00K 10-Q · filed 2014-11-07 | $417.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $105.00K 10-Q · filed 2014-08-14 | $215.00K 10-Q · filed 2014-08-14 | $313.00K derived: sum of 3 quarters · filed 2014-08-14 | $406.00K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $110.00K 10-Q · filed 2014-05-15 | $208.00K derived: sum of 2 quarters · filed 2014-05-15 | $301.00K derived: sum of 3 quarters · filed 2014-05-15 | $395.00K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $191.00K derived: sum of 2 quarters · filed 2014-03-31 | $285.00K derived: sum of 3 quarters · filed 2014-03-31 | $378.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $93.00K 10-Q · filed 2013-11-14 | $187.00K derived: sum of 2 quarters · filed 2013-11-14 | $280.00K 10-Q · filed 2013-11-14 | $590.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $94.00K 10-Q · filed 2013-08-14 | $187.00K 10-Q · filed 2013-08-14 | $497.00K derived: sum of 3 quarters · filed 2013-08-14 | $599.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $93.00K 10-Q · filed 2013-05-13 | $403.00K derived: sum of 2 quarters · filed 2013-05-13 | $505.00K derived: sum of 3 quarters · filed 2013-05-13 | |
| 2011-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $412.00K derived: sum of 2 quarters · filed 2013-03-29 | $614.00K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $102.00K 10-Q · filed 2012-11-09 | $304.00K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |